glp-1 grocery impact news GLP-1s may shrink appetite. But the bigger question is: What happens to the basket? Less food noise can mean fewer impulse buys, smaller portions, and better choices GLP-1 drug use cuts grocery

Phase 3 trials with TransCon CNP in achondroplasia and hypochondroplasia

unleash the inner gold thats inside of every dog

1 Beyond diabetes and obesity Cardiovascular disease In March 2024, the US Food and Drug Administration (FDA) approved Wegovy (semaglutide) for adults with cardiovascular disease (CVD) and either obesity and overweight to reduce the risk of cardiovascular death, heart attack, and stroke

Application Aprs le shampoing, appliquez des mi-longueurs aux pointes et massez le cuir chevelu

OXM infusion significantly reduced glycaemic excursion by augmenting GSIS in obese subjects with or without T2D (113)